语言

中文

下拉箭头
泰克生物—酵母与噬菌体展示CRO,纳米抗体与抗体药物开发专家

Anti-CD140a重组抗体|科研级 Olaratumab ( 奥拉妥单抗 )

询价与订购

  • 姓名*

  • 电话号码*

  • 电子邮件*

  • 产品名称*

  • 描述*

Anti-CD140a重组抗体|科研级 Olaratumab ( 奥拉妥单抗 )

货号:TKYR1233

  • ¥500/100ug
  • ¥3200/1mg
  • ¥6800/5mg
  • 定制报价/10mg以上
微信扫码
联系我们
说明书
MSDS
微信扫码
联系我们
  • 详细相关信息
  • 靶点背景信息
  • 实验方案&FAQ
  • 相关产品
  • 推荐服务
  • 详细相关信息

    Catalog Number

    TKYR1233

    Alias

    科研级 Olaratumab ( 奥拉妥单抗 ), Anti-CD140a Recombinant Antibody, Research Grade Olaratumab

    Molecular Name

    Olaratumab

    Size

    ¥500/100ug, ¥3200/1mg, ¥6800/5mg, 定制报价/10mg以上

    CAS Number

    1024603-93-7

    Isotype

    IgG1 Kappa

    Clonality

    Monoclonal

    Concentration

    1mg/ml

    Molecular Weight

    154 kDa

    Applications

    IF, IP, Neut, FuncS, ELISA, FC

    Source

    CHO Cells

    Purity

    ≥95% as determined by SDS-PAGE

    Buffer

    Supplied in PBS, PH7.5

    Protein Chemical Formula

    C6554H10076N1736O2048S40

    Target

    PDGFRA/PDGFR2/CD140a[Homo sapiens]

    Sequence

    Please contact our sales representative to learn more information about this reagents.

    Background

    Olaratumab, sold under the brand name Lartruvo, is a monoclonal antibody medication developed by Eli Lilly and Company for the treatment of solid tumors. It is directed against the platelet-derived growth factor receptor alpha. It was removed from the United States and European Union markets in 2019, due to insufficient proof of its medical advantage (see below "Medical uses").

    Storage

    该产品可在 2°C-8°C 下保存一个月,活性不会明显降低。在 -20°C 至 -80°C 下保存,可稳定保存十二个月。避免反复冻融,用冰袋运输。

    NOTE

    仅科研使用,不得用于人体或治疗用途。
    靶点背景信息
    实验方案&FAQ

    体验泰克生物—酵母与噬菌体展示CRO,纳米抗体与抗体药物开发专家的可靠服务,请订阅:

    底部背景